- recruitingPHASE2
A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)
This study is testing a new drug, pacritinib, for VEXAS syndrome. Researchers want to see if it's safe and helps reduce flare-ups and the need for steroids in people aged 18 and over with VEXAS.
United States · Canada · France - recruiting
AutoInflammatory Disease Alliance Registry (AIDA)
This project is building a secure online registry to collect health information from people with rare inflammatory conditions. The goal is to better understand these diseases, how they affect people, and how different treatments work. Your information could help doctors improve care for others.
Algeria · Australia · Belgium